title: Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
authors.forename: Clemens
authors.initials: C
authors.lastname: Warnke
authors.forename: Ortwin
authors.initials: O
authors.lastname: Adams
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Hartung
authors.forename: Bernd C
authors.initials: BC
authors.lastname: Kieseier
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004279:DNA, Viral / Q000097:blood* / Q000134:cerebrospinal fluid / Q000652:urine; D005500:Follow-Up Studies; D006801:Humans; D039441:Integrin alpha4 / Q000627:therapeutic use*; D007577:JC Virus / Q000235:genetics / Q000302:isolation & purification*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000821:virology*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D016133:Polymerase Chain Reaction / Q000592:standards / Q000706:statistics & numerical data; D012307:Risk Factors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004279:DNA, Viral; D000069442:Natalizumab; D039441:Integrin alpha4